High-dose antioxidants for central serous chorioretinopathy; The randomized placebo-controlled study

BMC Ophthalmology

Volumn 12, Issue 1, 2012, Pages

  Ratanasukon, Mansing ^a   Bhurayanontachai, Patama ^a   Jirarattanasopa, Pichai ^a  

^a PRINCE OF SONGKLA UNIVERSITY   (Thailand)

Author keywords

Antioxidants; Central serous chorioretinopathy

Indexed keywords

ANTIOXIDANT; FLUORESCEIN; FLUORESCENT DYE; PLACEBO;

ACUTE DISEASE; ADULT; ARTICLE; CENTRAL SEROUS RETINOPATHY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG COMBINATION; FEMALE; HUMAN; LOW LEVEL LASER THERAPY; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; PHYSIOLOGY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; VISUAL ACUITY;

ACUTE DISEASE; ADULT; ANTIOXIDANTS; CENTRAL SEROUS CHORIORETINOPATHY; DRUG COMBINATIONS; FEMALE; FLUORESCEIN; FLUORESCENT DYES; HUMANS; LASER THERAPY; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; PLACEBOS; PROSPECTIVE STUDIES; VISUAL ACUITY;

EID: 84864745241     PISSN: None     EISSN: 14712415     Source Type: Journal    
DOI: 10.1186/1471-2415-12-20     Document Type: Article

References (11)

1. Central serous chorioretinopathy. Klais CM, Ober MD, Ciardella AP, Yannuzzi LA, Retina vol II. 4th Mosby, St Louis, Ryan SJ, 2006 1135 1161
2. Long-term follow up of central serous chorioretinopathy. Gilbert CM, Owens SL, Smith PD, Fine SL, Br J Ophthalmol 1984 68 815 820 10.1136/bjo.68.11.815 6541945 (Pubitemid 15146084)
3. Systemic findings associated with central serous chorioretinopathy. Tittl MK, Spaide RF, Wong D, Pilotto E, Yannuzzi LA, Fisher YL, et al. Am J Ophthalmol 1999 128 63 68 10.1016/S0002-9394(99)00075-6 10482095 (Pubitemid 29315764)
4. Risk factors for central serous chorioretinopathy: A case-control study. Haimovici R, Koh S, Gagnon DR, Lehrfeld T, Wellik S, Ophthalmology 2004 111 244 249 10.1016/j.ophtha.2003.09.024 15019370 (Pubitemid 38183222)
5. Factors associated with reduced visual acuity during long-term follow-up of patients with idiopathic central serous chorioretinopathy. Loo RH, Scott IU, Flynn HW, Gass JD, Murray TG, Lewis ML, Retina 2002 22 19 24 10.1097/00006982-200202000-00004 11884873 (Pubitemid 41070746)
6. Digital indocyanine green videoangiography of central serous chorioretinopathy. Guyer DR, Yannuzzi LA, Slakter JS, Sorenson JA, Ho A, Orlock D, Arch Ophthalmol 1994 112 1057 1062 10.1001/archopht.1994.01090200063023 8053819 (Pubitemid 24272611)
7. Central serous chorioretinopathy and indocyanine green angiography. Piccolino FC, Borgia L, Retina 1994 14 231 242 10.1097/00006982-199414030-00008 7973118 (Pubitemid 24308054)
8. Choroidal capillary and venous congestion in central serous chorioretinopathy. Prünte C, Flammer J, Am J Ophthalmol 1996 121 26 34 8554078 (Pubitemid 26026078)
9. Photodynamic therapy for chronic central serous chorioretinopathy. Piccolino FC, Eandi CM, Ventre L, Rigualt de la Longrais RC, Grignolo FM, Retina 2003 23 752 763 10.1097/00006982-200312000-00002 14707823 (Pubitemid 38040573)
10. Chronic central serous chorioretinopathy: photodynamic therapy. Taban M, Boyer DS, Thomas EL, Taban M, Am J Ophthalmol 2004 137 1073 1080 10.1016/j.ajo.2004.01.043 15183792 (Pubitemid 38759356)
11. Acetazolamide for central serous retinopathy. Pikkle J, Beiran I, Ophir A, Miller B, Ophthalmology 2002 109 1723 1725 10.1016/S0161-6420(02)01157-0 12208723 (Pubitemid 35006406)